Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Option Care Health (OPCH) Shares Outstanding (Diluted Average) (2018 - 2026)

Option Care Health (OPCH) has disclosed Shares Outstanding (Diluted Average) for 14 consecutive years, with $158.2 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) fell 5.15% year-over-year to $158.2 million; the TTM value through Mar 2026 reached $158.2 million, down 5.15%, while the annual FY2025 figure was $163.4 million, 5.48% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $158.2 million in Q1 2026 for Option Care Health, down from $163.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $183.0 million in Q3 2022 and bottomed at $158.2 million in Q1 2026.
  • Average Shares Outstanding (Diluted Average) over 5 years is $174.5 million, with a median of $175.6 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Diluted Average) increased 1.04% in 2022 and then dropped 6.12% in 2025.
  • Option Care Health's Shares Outstanding (Diluted Average) stood at $182.1 million in 2022, then fell by 0.93% to $180.4 million in 2023, then dropped by 4.17% to $172.8 million in 2024, then fell by 5.48% to $163.4 million in 2025, then fell by 3.16% to $158.2 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $158.2 million, $163.4 million, and $164.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.